5AM makes around 10 – 15 deals per year in the in health-related industries they invest in. Looking at their deal sheet, startups who are best suited to do business with 5AM Ventures are those requiring a minimum of $10M to get their product or service off the ground and/or for a massive growth surge.

They stick close to their investments too with a total of 83 investments in just 43 companies as of late 2016. Already, they’ve been part of 7 IPOs and 9 acquisition deals. Early and late stage investments are the norm for them, as well as private equity investments for the right candidates. Some of their more impressive deals have included Bioz, Cleave Biosciences, Aprea AB, Pear Therapeutics, Millendo Therapeutics, Portal Instruments, Cidara Therapeutics, and a private equity deal in Relypsa.